Intuitive Surgical continues to target General Surgery with inguinal hernia study

Posted in Medical Device and Robotic Surgery

May 06, 2018 • 3 min read

One of Intuitive Surgical's four priorities in 2018 is to continue adoption in General Surgery. Through the first quarter of the year, the company is well on their way to over-achieving their four priorities. One way Intuitive can ensure their adoption and growth in general surgery is to show efficacy with their da Vinci versus traditional open procedures. ...


Allergan focuses on men to grow Botox franchise

Posted in Biotech

May 04, 2018 • 3 min read

Earlier this week, Allergan ($AGN) released earnings to mixed reviews from investors. In the past year, the stock has fallen from its 52 week high of ~$256 to its current levels of ~$148. This decline has put pressure on the management team to make changes and perform as Botox competition is looming and they are trying to navigate their Restasis patent expiration strategy, which up to this point, has not gone so smoothly. In an effort to calm investor concerns, Allergan CEO, Brent Saunders, ...

Zimmer Biomet Still Haunted By Supply Chain

Posted in Medical Device

May 02, 2018 • 3 min read

Zimmer Biomet has struggled with supply chain issues going back to their 58 page warning letter from the FDA in 2016. From their old CEO, David Dvorak, to their new one, Bryan Hanson, improving operational efficiencies has been the top priority. ...

Strong PROPEL Showing Lifts Intersect ENT in Q1

Posted in Medical Device

May 02, 2018 • 3 min read

Intersect ENT continued their solid revenue growth during Q1 of 2018, with total revenue of $24.7 million compared to $20.5 million in the same quarter of 2017. Overall, the company grew revenue 21% in the quarter. ...